Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Lamisil (terbinafine hydrochloride) Oral Granules, 125 mg & 187.5 mg
Company: Novartis Pharmaceuticals Corporation
NDA: 022071
Approval Date: 9/28/2007

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: March 12, 2009

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.